{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:54:31Z","timestamp":1793642071085,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jns.2025.125701","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T07:43:15Z","timestamp":1766043795000},"page":"125701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Clinical safety of ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis: Open-label extension of a phase 2\/3 randomized controlled study"],"prefix":"10.1016","volume":"480","author":[{"given":"Ryuji","family":"Kaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuishin","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.125701_bb0005","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2025.125701_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16140","article-title":"Breaking barriers with tofersen: enhancing therapeutic opportunities in amyotrophic lateral sclerosis","volume":"31","author":"Saini","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2025.125701_bb0015","first-page":"CD001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2025.125701_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"The Writing Group on bhelaf of the Edaravone (MCI-186) ALS 19 study group","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2025.125701_bb0025","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2337\/dc11-0009","article-title":"Diabetes as a cause of clinically significant functional cobalamin deficiency","volume":"34","author":"Solomon","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2025.125701_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12937-023-00900-6","article-title":"Methylmalonic acid, vitamin B12, and mortality risk in patients with preexisting coronary heart disease: a prospective cohort study","volume":"22","author":"Guo","year":"2023","journal-title":"Nutr. J."},{"key":"10.1016\/j.jns.2025.125701_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19274","article-title":"Association of plasma concentration of vitamin B12 with all-cause mortality in the general population in the Netherlands","volume":"3","author":"Flores-Guerrero","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jns.2025.125701_bb0040","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/hmg\/5.12.1851","article-title":"Cloning, mapping and RNA analysis of the human methionine synthase gene","volume":"5","author":"Li","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2025.125701_bb0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1212\/01.wnl.0000297193.53986.6f","article-title":"Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis","volume":"70","author":"Zoccolella","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.125701_bb0050","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/17482960902919360","article-title":"Homocysteine levels and amyotrophic lateral sclerosis: a possible link","volume":"11","author":"Zoccolella","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jns.2025.125701_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2009.12.017","article-title":"Methylcobalamin increases Erk1\/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model","volume":"222","author":"Okada","year":"2010","journal-title":"Exp. Neurol."},{"issue":"251","key":"10.1016\/j.jns.2025.125701_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.taap.2011.01.003","article-title":"Methyl vitamin B12 but not methylfolate rescues a motor neuron-like cell line from homocysteine-mediated cell death","volume":"15","author":"Hemendinger","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jns.2025.125701_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp-2018-319294","article-title":"Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II\/III randomised controlled study","volume":"90","author":"Kaji","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2025.125701_bb0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2022.0901","article-title":"Japan early-stage trial of ultrahigh-dose Methylcobalamin for ALS (JETALS) collaborators, Efficacy and safety of ultrahigh-dose methylcobalamin in early-stage amyotrophic lateral sclerosis: A randomized clinical trial","volume":"79","author":"Oki","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2025.125701_bb0075","series-title":"Ministry of Health and Welfare Severity Criteria for Ten CNS Degenerative Diseases","first-page":"1999","author":"Annual Report of the Research Committee of CNS Degenerative Diseases, The Ministry of Health and Welfare of Japan","year":"1998"},{"key":"10.1016\/j.jns.2025.125701_bb0080","first-page":"1551","article-title":"Criteria for disease stage and severity in amyotrophic lateral sclerosis [in Japanese]","volume":"95","author":"Moriwaka","year":"2005","journal-title":"Naika"},{"key":"10.1016\/j.jns.2025.125701_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2025.125701_bb0090","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis\/Riluzole study group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2025.125701_bb0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole study group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2025.125701_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mus.27946","article-title":"The effects of intervention with intravenous edaravone in study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis","volume":"68","author":"Brooks","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2025.125701_bb0105","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/cells12111523","article-title":"Current state and future directions in the therapy of ALS","volume":"12","author":"Tzeplaeff","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jns.2025.125701_bb0110","first-page":"223","article-title":"Real-world safety of the novel, free radical scavenger edaravone for amyotrophic lateral sclerosis patients: data from the post-marketing surveillance SUNRISE Japan, Neurol","volume":"9","author":"Ishizaki","year":"2021","journal-title":"Clin. Neurosci."},{"key":"10.1016\/j.jns.2025.125701_bb0115","series-title":"Package Insert","author":"Rozebalamin\u00ae (mecobalamin)","year":"2024"},{"issue":"1","key":"10.1016\/j.jns.2025.125701_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46124","article-title":"Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with type 2 diabetes","volume":"5","author":"Liu","year":"2022","journal-title":"JAMA Netw Open."},{"key":"10.1016\/j.jns.2025.125701_bb0125","first-page":"2486","article-title":"Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial","volume":"23","author":"Armitage","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2025.125701_bb0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacasi.2024.05.005","article-title":"Homocysteine metabolism, subclinical myocardial injury, and cardiovascular mortality in the general population","volume":"4","author":"Tan","year":"2024","journal-title":"JACC Asia"},{"key":"10.1016\/j.jns.2025.125701_bb0135","first-page":"677","article-title":"Influence of methylcobalamin and cyanocobalamin on the neoplastic process in rats","volume":"13","author":"Kal\u2019nev","year":"1977","journal-title":"Prikl. Biokhim. Mikrobiol."},{"key":"10.1016\/j.jns.2025.125701_bb0140","first-page":"164","article-title":"Effects of methylcobalamin on the proliferation of androgen-sensitive or estrogen-sensitive malignant cells in culture and in vivo","volume":"67","author":"Nishizawa","year":"1997","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"10.1016\/j.jns.2025.125701_bb0145","author":"Cancer Statistics in Japan-2025"},{"key":"10.1016\/j.jns.2025.125701_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp-2019-322213","article-title":"Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan","volume":"91","author":"Hayashi","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2025.125701_bb0155","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1038\/s41467-024-49954-y","article-title":"Temporal stratification of amyotrophic lateral sclerosis patients using disease progression patterns","volume":"15","author":"Amaral","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jns.2025.125701_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236804","article-title":"Diagnostic utility of the amyotrophic lateral sclerosis functional rating scale-revised to detect pharyngeal dysphagia in individuals with amyotrophic lateral sclerosis","volume":"15","author":"Chapin","year":"2020","journal-title":"PloS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25023214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25023214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T23:15:02Z","timestamp":1768950902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25023214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"alternative-id":["S0022510X25023214"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.125701","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical safety of ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis: Open-label extension of a phase 2\/3 randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.125701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125701"}}